In summary, we used the bioinformatics method to identify and validate hub genes of NKTCL; LMO3 and GRB14 may be the potential targets for diagnosis and treatment of NKTCL. This evidence concerns the gene LMO3 and extranodal nasal NK/T cell lymphoma.